Clinical Trial Update: Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports on evaluating aliskiren in combination with amlodipine for hypertensive patients not responding to ARB plus amlodipine; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• Amlodipine (amlodipine)

Snippet

Sponsor: Novartis | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED